nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study Meeting Abstract


Authors: Dockery, L.; Slomovitz, B.; Priebe, A.; Green, A.; Mathews, C.; Musa, F.; Puechl, A.; Birrer, M.; Spirtos, N.; Ding, L.; Schmid, A.; Navarro, W.; Moore, K.
Abstract Title: nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study
Meeting Title: Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer
Journal Title: Gynecologic Oncology
Volume: 190
Issue: Suppl. 1
Meeting Dates: 2024 Mar 15-18
Meeting Location: San Deigo, CA
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2024-11-01
Start Page: S286
Language: English
ACCESSION: WOS:001330731400413
DOI: 10.1016/j.ygyno.2024.07.425
PROVIDER: wos
Notes: Meeting Abstract: 2127 [TIP] -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Angela Kellen Green
    40 Green